Internationally recognized breast cancer researcher Dr. Samuel Aparicio (Aparicio Lab) has been named the 2022 recipient of the Canadian Cancer Society’s Robert L. Noble Prize.
Created in honour of Dr. Noble, an esteemed Canadian investigator whose research in the 1950s led to the discovery of vinblastine, a widely used anticancer drug, the Robert L. Noble Prize is given for outstanding achievements in basic biomedical cancer research.
Please join us in congratulating Sam!